GeneDx to Participate in Upcoming Investor Conferences
23 5월 2024 - 5:05AM
GeneDx (Nasdaq: WGS), a leader in delivering improved health
outcomes through genomic insights, today announced that company
management will participate in two upcoming investor conferences in
June:
- Jefferies Healthcare Conference
- New York City, New York Fireside chat on Wednesday, June 5
at 9:00 a.m. ET
- 44th Annual Goldman Sachs Global
Healthcare Conference - Miami, Florida Fireside chat on Monday,
June 10 at 3:20 p.m. ET
Live and archived webcasts of the presentation will be available
on the “Events” section of the GeneDx investor relations website at
ir.genedx.com/news-events/events.
About GeneDx
At GeneDx (Nasdaq: WGS), we believe that everyone deserves
personalized, targeted medical care—and that it all begins with a
genetic diagnosis. Fueled by one of the world’s largest rare
disease data sets, our industry-leading exome and genome tests
translate complex genomic data into clinical answers that unlock
personalized health plans, accelerate drug discovery, and improve
health system efficiencies. It all starts with a single test. For
more information, please visit genedx.com and connect with us on
LinkedIn, X, Facebook, and Instagram.
Investor Relations Contact:investors@GeneDx.com
Media Contact:press@GeneDx.com
GeneDx (NASDAQ:WGS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
GeneDx (NASDAQ:WGS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024